Analysts project an average annual growth rate of 56% for Bi...
Analysts project an average annual growth rate of 56% for Bio-Path Holdings to meet its breakeven date. The company's lack of debt is unusual for a loss-making biotech and reduces investment risk.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
1
Translate
Report
3811 Views
Comment
Sign in to post a comment
NECKMINUTE 007
:
that's a comment you made by law I hope you don't false advertise
NECKMINUTE 007 : that's a comment you made by law I hope you don't false advertise